chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: fevers for three hours every night ranging from 101-103; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fevers for three hours every night ranging from 101-103) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006B21A and 042B212A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (fevers for three hours every night ranging from 101-103). At the time of the report, PYREXIA (fevers for three hours every night ranging from 101-103) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Treatment Information was reported. No concomitant product information was reported.   This case was linked to MOD-2021-109873 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: No specific follow-up information recorded. On 06-May-2021: No specific follow-up information recorded. On 02-Jun-2021: Non significant follow up address updated and follow up document attached.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Influenza like illness, Neck pain, Pain, Pain in extremity
Clinical narrative: I was so dizzy I almost had to pull over; pain in right arm; pain in right jaw down to her right side of her neck; general pain similar to the flu; general pain similar to the flu; Pain in my neck; vertigo; pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (I was so dizzy I almost had to pull over), PAIN IN EXTREMITY (pain in right arm), PAIN IN JAW (pain in right jaw down to her right side of her neck), PAIN (general pain similar to the flu) and INFLUENZA LIKE ILLNESS (general pain similar to the flu) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-May-2021 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (I was so dizzy I almost had to pull over), PAIN IN EXTREMITY (pain in right arm), PAIN IN JAW (pain in right jaw down to her right side of her neck), PAIN (general pain similar to the flu), INFLUENZA LIKE ILLNESS (general pain similar to the flu), NECK PAIN (Pain in my neck), VERTIGO (vertigo) and VACCINATION SITE PAIN (pain at injection site). At the time of the report, DIZZINESS (I was so dizzy I almost had to pull over) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Pain in jaw, Vaccination site pain, Vertigo
Clinical narrative: I was so dizzy I almost had to pull over; pain in right arm; pain in right jaw down to her right side of her neck; general pain similar to the flu; general pain similar to the flu; Pain in my neck; vertigo; pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (I was so dizzy I almost had to pull over), PAIN IN EXTREMITY (pain in right arm), PAIN IN JAW (pain in right jaw down to her right side of her neck), PAIN (general pain similar to the flu) and INFLUENZA LIKE ILLNESS (general pain similar to the flu) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-May-2021 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (I was so dizzy I almost had to pull over), PAIN IN EXTREMITY (pain in right arm), PAIN IN JAW (pain in right jaw down to her right side of her neck), PAIN (general pain similar to the flu), INFLUENZA LIKE ILLNESS (general pain similar to the flu), NECK PAIN (Pain in my neck), VERTIGO (vertigo) and VACCINATION SITE PAIN (pain at injection site). At the time of the report, DIZZINESS (I was so dizzy I almost had to pull over) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Tachycardia, Vaccination site pain
Clinical narrative: tachycardia; vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (vaccination site pain) and TACHYCARDIA (tachycardia) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 009C21A and 0313B1A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (vaccination site pain) and TACHYCARDIA (tachycardia). At the time of the report, VACCINATION SITE PAIN (vaccination site pain) and TACHYCARDIA (tachycardia) outcome was unknown.            Concomitant product use was not provided by the reporter.  Treatment information was not provided.   This case was linked to MOD-2021-109959 (Patient Link).   Reporter did not allow further contact
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Aphonia, Bone pain, Chills, Cough, Feeling abnormal
Clinical narrative: rash, on chest, arms, wrists; heard something in the bottom of lungs; felt like I was getting pneumonia; sore throat; congestion in my nose; lost my voice; dry cough; slept all day long; chills; felt very ill; bones hurt; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (felt very ill), BONE PAIN (bones hurt), SOMNOLENCE (slept all day long), OROPHARYNGEAL PAIN (sore throat) and NASAL CONGESTION (congestion in my nose) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  Concomitant products included PAIN RELIEF BACK PAIN for Back pain.    On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, the patient experienced MALAISE (felt very ill), BONE PAIN (bones hurt) and CHILLS (chills). On 25-Apr-2021, the patient experienced SOMNOLENCE (slept all day long). On 27-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat), NASAL CONGESTION (congestion in my nose), APHONIA (lost my voice), COUGH (dry cough) and FEELING ABNORMAL (felt like I was getting pneumonia). On 05-May-2021, the patient experienced FEELING ABNORMAL (heard something in the bottom of lungs). On an unknown date, the patient experienced RASH (rash, on chest, arms, wrists). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, MALAISE (felt very ill), BONE PAIN (bones hurt), SOMNOLENCE (slept all day long), OROPHARYNGEAL PAIN (sore throat), NASAL CONGESTION (congestion in my nose), APHONIA (lost my voice), COUGH (dry cough), FEELING ABNORMAL (heard something in the bottom of lungs), FEELING ABNORMAL (felt like I was getting pneumonia) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication included Zpack  Concomitant products included 24 other daily medications (names unknown at call) for an unknown indication.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Nasal congestion, Oropharyngeal pain, Rash, Somnolence
Clinical narrative: rash, on chest, arms, wrists; heard something in the bottom of lungs; felt like I was getting pneumonia; sore throat; congestion in my nose; lost my voice; dry cough; slept all day long; chills; felt very ill; bones hurt; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (felt very ill), BONE PAIN (bones hurt), SOMNOLENCE (slept all day long), OROPHARYNGEAL PAIN (sore throat) and NASAL CONGESTION (congestion in my nose) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  Concomitant products included PAIN RELIEF BACK PAIN for Back pain.    On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, the patient experienced MALAISE (felt very ill), BONE PAIN (bones hurt) and CHILLS (chills). On 25-Apr-2021, the patient experienced SOMNOLENCE (slept all day long). On 27-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat), NASAL CONGESTION (congestion in my nose), APHONIA (lost my voice), COUGH (dry cough) and FEELING ABNORMAL (felt like I was getting pneumonia). On 05-May-2021, the patient experienced FEELING ABNORMAL (heard something in the bottom of lungs). On an unknown date, the patient experienced RASH (rash, on chest, arms, wrists). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, MALAISE (felt very ill), BONE PAIN (bones hurt), SOMNOLENCE (slept all day long), OROPHARYNGEAL PAIN (sore throat), NASAL CONGESTION (congestion in my nose), APHONIA (lost my voice), COUGH (dry cough), FEELING ABNORMAL (heard something in the bottom of lungs), FEELING ABNORMAL (felt like I was getting pneumonia) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication included Zpack  Concomitant products included 24 other daily medications (names unknown at call) for an unknown indication.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Headache, Incorrect route of product administration, Pain
Clinical narrative: little sore; little bit of a cough; light headache; injected in the way back of my arm far back; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (little sore), COUGH (little bit of a cough), INCORRECT ROUTE OF PRODUCT ADMINISTRATION (injected in the way back of my arm far back) and HEADACHE (light headache) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A and 039B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Apr-2021, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (injected in the way back of my arm far back). On an unknown date, the patient experienced PAIN (little sore), COUGH (little bit of a cough) and HEADACHE (light headache). At the time of the report, PAIN (little sore) and COUGH (little bit of a cough) outcome was unknown and INCORRECT ROUTE OF PRODUCT ADMINISTRATION (injected in the way back of my arm far back) and HEADACHE (light headache) had resolved. Not Provided          Action taken with mRNA-1273 in response to the events was not Applicable. No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (COVID-19). At the time of the report, COVID-19 (COVID-19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported. For mRNA-1273 (Moderna COVID-19 Vaccine) (unknown), the reporter did not provide any causality assessments.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Blood count, Lymphadenopathy, Rheumatoid arthritis
Clinical narrative: Rheumatoid arthritis flare up; Swollen lymph nodes, the lymph nodes in his right armpit swelled up; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of RHEUMATOID ARTHRITIS (Rheumatoid arthritis flare up) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product UPADACITINIB (RINVOQ) for an unknown indication.    No reported medical history.  Concurrent medical conditions included Chronic lymphocytic leukemia in 2018. Concomitant products included LISINOPRIL for Blood pressure abnormal.   In January 2021, the patient started UPADACITINIB (RINVOQ) (Oral) 1 dosage form. In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In March 2021, the patient experienced LYMPHADENOPATHY (Swollen lymph nodes, the lymph nodes in his right armpit swelled up). On 17-Mar-2021, the patient experienced RHEUMATOID ARTHRITIS (Rheumatoid arthritis flare up) (seriousness criterion medically significant). On 18-Mar-2021, RHEUMATOID ARTHRITIS (Rheumatoid arthritis flare up) had resolved. At the time of the report, LYMPHADENOPATHY (Swollen lymph nodes, the lymph nodes in his right armpit swelled up) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In March 2021, Blood count: 3000 (High) White count was up 3000 and 3000 (Inconclusive) White count had gone down 3000 after few weeks..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not provided.    This case was linked to MOD-2021-113371 (Patient Link).; Sender's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
Sex: U
Vaccine: COVID19
Symptoms: Dry mouth, Erythema, Hypersensitivity, Myalgia, Vision blurred
Clinical narrative: Muscle ache; Redness; Allergy; Blurry vision; Dry mouth,Getting a fungus; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (Allergy), VISION BLURRED (Blurry vision), DRY MOUTH (Dry mouth,Getting a fungus), MYALGIA (Muscle ache) and ERYTHEMA (Redness) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  The patient's past medical history included No adverse event. Concomitant products included CYANOCOBALAMIN, PYRIDOXINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE (VITAMIN B 1-6-12) and Blood pressure medication for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-May-2021, the patient experienced HYPERSENSITIVITY (Allergy), VISION BLURRED (Blurry vision) and DRY MOUTH (Dry mouth,Getting a fungus). On 09-May-2021, the patient experienced MYALGIA (Muscle ache) and ERYTHEMA (Redness). At the time of the report, HYPERSENSITIVITY (Allergy), VISION BLURRED (Blurry vision), DRY MOUTH (Dry mouth,Getting a fungus), MYALGIA (Muscle ache) and ERYTHEMA (Redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment with Tylenol was provided pertained to the symptoms experienced.
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: Patient stated her friend had the second Moderna vaccine and she was totally exhausted.; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Patient stated her friend had the second Moderna vaccine and she was totally exhausted.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Patient stated her friend had the second Moderna vaccine and she was totally exhausted.). At the time of the report, FEELING ABNORMAL (Patient stated her friend had the second Moderna vaccine and she was totally exhausted.) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-114278 (E2B Linked Report); Sender's Comments:  MODERNATX, INC.-MOD-2021-114278:
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Rash
Clinical narrative: Rash; Had Migraines; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash) and MIGRAINE (Had Migraines) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (Rash) and MIGRAINE (Had Migraines). At the time of the report, RASH (Rash) and MIGRAINE (Had Migraines) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD21-087683, US-MODERNATX, INC.-MOD-2021-114269; Sender's Comments:  MOD21-087683: US-MODERNATX, INC.-MOD-2021-114269:
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Peripheral swelling, Pyrexia, Vaccination site pain
Clinical narrative: swelling under armpit of administered arm; Pain at injection site; fever; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swelling under armpit of administered arm), VACCINATION SITE PAIN (Pain at injection site) and PYREXIA (fever) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination.     Concurrent medical conditions included Spina bifida. Concomitant products included SULFAMETHOXAZOLE, TRIMETHOPRIM (BACTRIM DS) for an unknown indication.   On 05-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-May-2021, the patient experienced PYREXIA (fever). On 07-May-2021, the patient experienced PERIPHERAL SWELLING (swelling under armpit of administered arm) and VACCINATION SITE PAIN (Pain at injection site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (swelling under armpit of administered arm), VACCINATION SITE PAIN (Pain at injection site) and PYREXIA (fever) outcome was unknown. Not Provided     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the events was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Chromaturia, Faeces discoloured
Clinical narrative: Dark urine; Yellow stools; This spontaneous case was reported by a consumer and describes the occurrence of FAECES DISCOLOURED (Yellow stools) and CHROMATURIA (Dark urine) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced FAECES DISCOLOURED (Yellow stools). On an unknown date, the patient experienced CHROMATURIA (Dark urine). At the time of the report, FAECES DISCOLOURED (Yellow stools) and CHROMATURIA (Dark urine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to US-MODERNATX, INC.-MOD-2021-114672 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: Significant follow up; Sender's Comments: Very limited information regarding these events has been provided at this time. Further information has been requested. US-MODERNATX, INC.-MOD-2021-114672:reporter's case
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain, Pain in extremity
Clinical narrative: muscle pain is now in both of her arms; so much pain; muscle pain in her legs; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (muscle pain in her legs), PAIN (so much pain) and MYALGIA (muscle pain is now in both of her arms) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0044A21A and 024M21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included METOPROLOL, AMLODIPINE, CLONIDINE and IRBESARTAN for an unknown indication.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Mar-2021, the patient experienced PAIN IN EXTREMITY (muscle pain in her legs). On 07-May-2021, the patient experienced PAIN (so much pain). On an unknown date, the patient experienced MYALGIA (muscle pain is now in both of her arms). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (muscle pain in her legs), PAIN (so much pain) and MYALGIA (muscle pain is now in both of her arms) outcome was unknown. Not Provided          Treatment medication include Tylenol, Aleve, Tramadol  .  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable. Patient called in after receiving her 2nd dose of the Moderna covid vaccine on 19mar2021. On 20mar2021 she experienced muscle pain in her legs which lasted for 3 weeks. She did go to her PCP who prescribed her pain medication. After the pain was relieved from her legs, muscle pain is now in both of her arms which started 3 weeks ago. She gets some relief from Tylenol/Aleve but not for a long period of time.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Chapped lips, Lip dry, Lip erythema, Oral discomfort, Pain
Clinical narrative: sticky; Chapped lips; so dry; peeling; sore; red like she had lipstick on; pieces were sticking out; This spontaneous case was reported by a consumer and describes the occurrence of CHAPPED LIPS (Chapped lips), LIP DRY (so dry), SKIN EXFOLIATION (peeling), PAIN (sore) and LIP ERYTHEMA (red like she had lipstick on) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included DIAZEPAM for Anxiety, IMIPRAMINE for Depression, MESALAZINE (PENTASA) for Ulcerative colitis.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced CHAPPED LIPS (Chapped lips), LIP DRY (so dry), SKIN EXFOLIATION (peeling), PAIN (sore), LIP ERYTHEMA (red like she had lipstick on) and ORAL DISCOMFORT (pieces were sticking out). On an unknown date, the patient experienced STICKY SKIN (sticky). At the time of the report, CHAPPED LIPS (Chapped lips), LIP DRY (so dry), SKIN EXFOLIATION (peeling), PAIN (sore), LIP ERYTHEMA (red like she had lipstick on), ORAL DISCOMFORT (pieces were sticking out) and STICKY SKIN (sticky) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MODERNATX, INC.-MOD-2021-114492 (E2B Linked Report).; Sender's Comments:  MODERNATX, INC.-MOD-2021-114492:Case for coworker
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Skin exfoliation, Sticky skin
Clinical narrative: sticky; Chapped lips; so dry; peeling; sore; red like she had lipstick on; pieces were sticking out; This spontaneous case was reported by a consumer and describes the occurrence of CHAPPED LIPS (Chapped lips), LIP DRY (so dry), SKIN EXFOLIATION (peeling), PAIN (sore) and LIP ERYTHEMA (red like she had lipstick on) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included DIAZEPAM for Anxiety, IMIPRAMINE for Depression, MESALAZINE (PENTASA) for Ulcerative colitis.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced CHAPPED LIPS (Chapped lips), LIP DRY (so dry), SKIN EXFOLIATION (peeling), PAIN (sore), LIP ERYTHEMA (red like she had lipstick on) and ORAL DISCOMFORT (pieces were sticking out). On an unknown date, the patient experienced STICKY SKIN (sticky). At the time of the report, CHAPPED LIPS (Chapped lips), LIP DRY (so dry), SKIN EXFOLIATION (peeling), PAIN (sore), LIP ERYTHEMA (red like she had lipstick on), ORAL DISCOMFORT (pieces were sticking out) and STICKY SKIN (sticky) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MODERNATX, INC.-MOD-2021-114492 (E2B Linked Report).; Sender's Comments:  MODERNATX, INC.-MOD-2021-114492:Case for coworker
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Myalgia
Clinical narrative: little cough; Sore arm; COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19), COUGH (little cough) and MYALGIA (Sore arm) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced COVID-19 (COVID-19). On an unknown date, the patient experienced COUGH (little cough) and MYALGIA (Sore arm). At the time of the report, COVID-19 (COVID-19), COUGH (little cough) and MYALGIA (Sore arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications provided. No treatment information provided.   This case was linked to MOD-2021-114477 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chills, Diarrhoea, Urinary incontinence
Clinical narrative: Stomach ache; Urinary incompetence; Diarrhea; Chills; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach ache), URINARY INCONTINENCE (Urinary incompetence), DIARRHOEA (Diarrhea) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomach ache), URINARY INCONTINENCE (Urinary incompetence), DIARRHOEA (Diarrhea) and CHILLS (Chills). At the time of the report, ABDOMINAL PAIN UPPER (Stomach ache), URINARY INCONTINENCE (Urinary incompetence), DIARRHOEA (Diarrhea) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided.  Treatment medication was not provided.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Vaccination site erythema
Clinical narrative: red marks on the shoulder where the injection was given; big red mark and a red mark right under it; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (red marks on the shoulder where the injection was given) and ERYTHEMA (big red mark and a red mark right under it) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043-B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  The patient's past medical history included No adverse reaction. Concomitant products included MULTIVITAMINS [VITAMINS NOS], PARACETAMOL (TYLENOL) and IBUPROFEN for an unknown indication.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, the patient experienced VACCINATION SITE ERYTHEMA (red marks on the shoulder where the injection was given) and ERYTHEMA (big red mark and a red mark right under it). At the time of the report, VACCINATION SITE ERYTHEMA (red marks on the shoulder where the injection was given) and ERYTHEMA (big red mark and a red mark right under it) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Insomnia, Pain in extremity
Clinical narrative: couldn't sleep for 2 days; Pain started with one side of hip then both; Pain that went down my leg to my foot, feeling it going down my thighs and knees; Experiencing some pain in arm too; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (couldn't sleep for 2 days), ARTHRALGIA (Pain started with one side of hip then both), PAIN IN EXTREMITY (Pain that went down my leg to my foot, feeling it going down my thighs and knees) and PAIN IN EXTREMITY (Experiencing some pain in arm too) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 05-May-2021, the patient experienced INSOMNIA (couldn't sleep for 2 days), ARTHRALGIA (Pain started with one side of hip then both), PAIN IN EXTREMITY (Pain that went down my leg to my foot, feeling it going down my thighs and knees) and PAIN IN EXTREMITY (Experiencing some pain in arm too). At the time of the report, INSOMNIA (couldn't sleep for 2 days), ARTHRALGIA (Pain started with one side of hip then both), PAIN IN EXTREMITY (Pain that went down my leg to my foot, feeling it going down my thighs and knees) and PAIN IN EXTREMITY (Experiencing some pain in arm too) outcome was unknown. Not Provided          This case was linked to US-MODERNATX, INC.-MOD-2021-049289, US-MODERNATX, INC.-MOD-2021-114700 ; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-049289:Same reporter US-MODERNATX, INC.-MOD-2021-114700:Same reporter
Age: 73.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Depression, Discomfort, Fear, Headache, Nausea
Clinical narrative: anxious; discomfort; afraid; hot arm, at the injection site; lot of headache, from the neck to the forehead; little of nausea sometimes; red arm, at the injection site; swollen arm, at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of DEPRESSION (anxious), DISCOMFORT (discomfort), FEAR (afraid), VACCINATION SITE WARMTH (hot arm, at the injection site) and HEADACHE (lot of headache, from the neck to the forehead) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL ALLERGY [DIPHENHYDRAMINE HYDROCHLORIDE]) cream for an unknown indication.    No medical history was provided by the reporter.  Concurrent medical conditions included Blood pressure high (patient has hypertension), Thyroid disorder NOS and Anxiety. Concomitant products included METOPROLOL for Blood pressure high, LEVOTHYROXINE SODIUM (SYNTHROID) for Thyroid disorder NOS, ALPRAZOLAM (XANAX) for an unknown indication.   On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL ALLERGY [DIPHENHYDRAMINE HYDROCHLORIDE]) (unknown route) at an unspecified dose. On an unknown date, the patient experienced DEPRESSION (anxious), DISCOMFORT (discomfort), FEAR (afraid), VACCINATION SITE WARMTH (hot arm, at the injection site), HEADACHE (lot of headache, from the neck to the forehead), NAUSEA (little of nausea sometimes), VACCINATION SITE ERYTHEMA (red arm, at the injection site) and VACCINATION SITE SWELLING (swollen arm, at the injection site). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. At the time of the report, DEPRESSION (anxious), DISCOMFORT (discomfort), FEAR (afraid), VACCINATION SITE WARMTH (hot arm, at the injection site), HEADACHE (lot of headache, from the neck to the forehead), NAUSEA (little of nausea sometimes), VACCINATION SITE ERYTHEMA (red arm, at the injection site) and VACCINATION SITE SWELLING (swollen arm, at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   other treatment include : Ice at the injection site Events Verbatim
Age: 73.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: anxious; discomfort; afraid; hot arm, at the injection site; lot of headache, from the neck to the forehead; little of nausea sometimes; red arm, at the injection site; swollen arm, at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of DEPRESSION (anxious), DISCOMFORT (discomfort), FEAR (afraid), VACCINATION SITE WARMTH (hot arm, at the injection site) and HEADACHE (lot of headache, from the neck to the forehead) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL ALLERGY [DIPHENHYDRAMINE HYDROCHLORIDE]) cream for an unknown indication.    No medical history was provided by the reporter.  Concurrent medical conditions included Blood pressure high (patient has hypertension), Thyroid disorder NOS and Anxiety. Concomitant products included METOPROLOL for Blood pressure high, LEVOTHYROXINE SODIUM (SYNTHROID) for Thyroid disorder NOS, ALPRAZOLAM (XANAX) for an unknown indication.   On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL ALLERGY [DIPHENHYDRAMINE HYDROCHLORIDE]) (unknown route) at an unspecified dose. On an unknown date, the patient experienced DEPRESSION (anxious), DISCOMFORT (discomfort), FEAR (afraid), VACCINATION SITE WARMTH (hot arm, at the injection site), HEADACHE (lot of headache, from the neck to the forehead), NAUSEA (little of nausea sometimes), VACCINATION SITE ERYTHEMA (red arm, at the injection site) and VACCINATION SITE SWELLING (swollen arm, at the injection site). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. At the time of the report, DEPRESSION (anxious), DISCOMFORT (discomfort), FEAR (afraid), VACCINATION SITE WARMTH (hot arm, at the injection site), HEADACHE (lot of headache, from the neck to the forehead), NAUSEA (little of nausea sometimes), VACCINATION SITE ERYTHEMA (red arm, at the injection site) and VACCINATION SITE SWELLING (swollen arm, at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   other treatment include : Ice at the injection site Events Verbatim
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Feeling abnormal, Nausea
Clinical narrative: Horrible rash all over her body/hives; Horrible rash all over her body/hives; nausea; Fogginess; dizziness; fever; chills; vomiting; tiredness; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Fogginess), URTICARIA (Horrible rash all over her body/hives), DIZZINESS (dizziness), PYREXIA (fever) and CHILLS (chills) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, the patient experienced FEELING ABNORMAL (Fogginess), DIZZINESS (dizziness), PYREXIA (fever), CHILLS (chills), VOMITING (vomiting), FATIGUE (tiredness) and NAUSEA (nausea). On 30-Apr-2021, the patient experienced URTICARIA (Horrible rash all over her body/hives) and RASH (Horrible rash all over her body/hives). On 04-May-2021, FEELING ABNORMAL (Fogginess), DIZZINESS (dizziness), PYREXIA (fever), CHILLS (chills), VOMITING (vomiting), FATIGUE (tiredness) and NAUSEA (nausea) had resolved. At the time of the report, URTICARIA (Horrible rash all over her body/hives) and RASH (Horrible rash all over her body/hives) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were reported No treatment medications were reported
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash, Urticaria, Vomiting
Clinical narrative: Horrible rash all over her body/hives; Horrible rash all over her body/hives; nausea; Fogginess; dizziness; fever; chills; vomiting; tiredness; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Fogginess), URTICARIA (Horrible rash all over her body/hives), DIZZINESS (dizziness), PYREXIA (fever) and CHILLS (chills) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, the patient experienced FEELING ABNORMAL (Fogginess), DIZZINESS (dizziness), PYREXIA (fever), CHILLS (chills), VOMITING (vomiting), FATIGUE (tiredness) and NAUSEA (nausea). On 30-Apr-2021, the patient experienced URTICARIA (Horrible rash all over her body/hives) and RASH (Horrible rash all over her body/hives). On 04-May-2021, FEELING ABNORMAL (Fogginess), DIZZINESS (dizziness), PYREXIA (fever), CHILLS (chills), VOMITING (vomiting), FATIGUE (tiredness) and NAUSEA (nausea) had resolved. At the time of the report, URTICARIA (Horrible rash all over her body/hives) and RASH (Horrible rash all over her body/hives) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were reported No treatment medications were reported
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site bruising, Wrong technique in device usage process
Clinical narrative: A lot of bruising on the arm where the needle was inserted; More bleeding the second time than the first,  there was more difficulty getting the needle in the second time and there was more blood; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (A lot of bruising on the arm where the needle was inserted) and WRONG TECHNIQUE IN DEVICE USAGE PROCESS (More bleeding the second time than the first,  there was more difficulty getting the needle in the second time and there was more blood) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE BRUISING (A lot of bruising on the arm where the needle was inserted) and WRONG TECHNIQUE IN DEVICE USAGE PROCESS (More bleeding the second time than the first,  there was more difficulty getting the needle in the second time and there was more blood). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE BRUISING (A lot of bruising on the arm where the needle was inserted) and WRONG TECHNIQUE IN DEVICE USAGE PROCESS (More bleeding the second time than the first,  there was more difficulty getting the needle in the second time and there was more blood) outcome was unknown. Not Provided          Concomitant product use was not provided by the reporter.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Very bad headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Very bad headache) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025C21A and 040B21A) for COVID-19 vaccination.     Concurrent medical conditions included Seasonal allergy and Food allergy.   On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEADACHE (Very bad headache). At the time of the report, HEADACHE (Very bad headache) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided by reporter. No treatment medications were reported.   This case was linked to MOD-2021-116457 (Patient Link).
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Bronchitis, Illness, Product dose omission issue, Sinusitis
Clinical narrative: unable to get 2nd dose of vaccine until 50 days after 1st dose.; got very sick; bronchitis; sinusitis; This spontaneous case was reported by a patient and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (unable to get 2nd dose of vaccine until 50 days after 1st dose.), ILLNESS (got very sick), BRONCHITIS (bronchitis) and SINUSITIS (sinusitis) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No Medical History information was reported.    On 30-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (unable to get 2nd dose of vaccine until 50 days after 1st dose.), ILLNESS (got very sick), BRONCHITIS (bronchitis) and SINUSITIS (sinusitis). At the time of the report, PRODUCT DOSE OMISSION ISSUE (unable to get 2nd dose of vaccine until 50 days after 1st dose.), ILLNESS (got very sick), BRONCHITIS (bronchitis) and SINUSITIS (sinusitis) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.